Operational team

Operational team

Team
 » 
Operational team
Read more
Per von Mentzer
Portrait photo

Per von Mentzer

Chief executive officer and board member since 2018
Read more
Read more
Bengt von Mentzer
Portrait photo

Bengt von Mentzer

Founder and Chief scientific advisor, board member since 2008.
Read more
Read more
David Kendall
Portrait photo

David Kendall

Chief scientific officer and board member since 2010.
Read more
Read more
Carl-Magnus Andersson
Portrait photo

Carl-Magnus Andersson

Scientific advisor / Chemistry and formulation
Read more
Jarkko Kalliomäki
Portrait photo

Jarkko Kalliomäki

Read more
Christina Balslev Rindshøj
Portrait photo

Christina Balslev Rindshøj

Read more
Ann Christine Korsgaard
Portrait photo

Ann Christine Korsgaard

Read more
Carl-Magnus Andersson
Portrait photo

Carl-Magnus Andersson

Read more
Jarkko Kalliomäki
Portrait photo

Jarkko Kalliomäki

Read more
Kerstin Kenne
Portrait photo

Kerstin Kenne

Scientific advisor / toxicology
Read more
Christina Balslev Rindshøj
Portrait photo

Christina Balslev Rindshøj

Read more
Ann Christine Korsgaard
Portrait photo

Ann Christine Korsgaard

Read more
Carl-Magnus Andersson
Portrait photo

Carl-Magnus Andersson

Read more
Jarkko Kalliomäki
Portrait photo

Jarkko Kalliomäki

Read more
Christina Balslev Rindshøj
Portrait photo

Christina Balslev Rindshøj

Read more
Rikke Winther
Portrait photo

Rikke Winther

Scientific advisor / clinical
Read more
Ann Christine Korsgaard
Portrait photo

Ann Christine Korsgaard

Read more
Carl-Magnus Andersson
Portrait photo

Carl-Magnus Andersson

Read more
Jarkko Kalliomäki
Portrait photo

Jarkko Kalliomäki

Read more
Christina Balslev Rindshøj
Portrait photo

Christina Balslev Rindshøj

Read more
Ann Christine Korsgaard
Portrait photo

Ann Christine Korsgaard

Scientific advisor / regulatory

Latest news

View all
December 22, 2022

PharmNovo at Biostock

CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

Read more
December 22, 2022

Seasons Greetings 2022

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

Read more
October 11, 2022

Strengthening the team

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager

Read more
September 20, 2022

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Awesome 👌